Themis Medicare Limited (NSE:THEMISMED)

Market Cap	12.13B
Revenue (ttm)	4.06B
Net Income (ttm)	298.33M
Shares Out	n/a
EPS (ttm)	3.24
PE Ratio	40.65
Forward PE	n/a
Dividend	0.50 (0.37%)
Ex-Dividend Date	Jul 12, 2024

Volume	34,507
Average Volume	137,873
Open	132.66
Previous Close	131.67
Day's Range	130.82 - 133.00
52-Week Range	115.00 - 317.00
Beta	-0.10
RSI	43.53
Earnings Date	May 30, 2025

About Themis Medicare

Themis Medicare Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India and internationally. The company offers active pharmaceutical ingredients (APIs) and formulations for use in various therapeutic areas, including anti-tuberculosis, anti-malarials, cardiology, pain management, anti-infectives, haematinics, health and nutrition, anaesthesia, gynecology, and orthopedics. It also offers anti-inflammatory drugs and other drugs. The company was formerly known as Themis Chemicals and changed its name to Th...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1952
• Employees: 1,509
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: THEMISMED

Financial Performance

In 2024, Themis Medicare's revenue was 4.06 billion, an increase of 6.22% compared to the previous year's 3.82 billion. Earnings were 298.33 million, a decrease of -31.46%.